

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 8.49394905 |
| 2 | exogenous drug catabolic process (GO:0042738) | 7.43577457 |
| 3 | drug catabolic process (GO:0042737) | 7.18772871 |
| 4 | urea metabolic process (GO:0019627) | 6.47068692 |
| 5 | cellular glucuronidation (GO:0052695) | 6.31712907 |
| 6 | drug metabolic process (GO:0017144) | 6.29092369 |
| 7 | omega-hydroxylase P450 pathway (GO:0097267) | 6.18114729 |
| 8 | uronic acid metabolic process (GO:0006063) | 6.13563894 |
| 9 | glucuronate metabolic process (GO:0019585) | 6.13563894 |
| 10 | ethanol oxidation (GO:0006069) | 6.01283163 |
| 11 | urea cycle (GO:0000050) | 5.96181154 |
| 12 | nitrogen cycle metabolic process (GO:0071941) | 5.90807165 |
| 13 | intestinal absorption (GO:0050892) | 5.77591866 |
| 14 | angiotensin maturation (GO:0002003) | 5.68331180 |
| 15 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.57400968 |
| 16 | regulation of triglyceride catabolic process (GO:0010896) | 5.54746669 |
| 17 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 5.26628257 |
| 18 | bile acid and bile salt transport (GO:0015721) | 5.25037129 |
| 19 | intestinal cholesterol absorption (GO:0030299) | 5.04073772 |
| 20 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.03876005 |
| 21 | L-phenylalanine catabolic process (GO:0006559) | 5.03876005 |
| 22 | complement activation, alternative pathway (GO:0006957) | 5.03029033 |
| 23 | glyoxylate metabolic process (GO:0046487) | 4.94224867 |
| 24 | hormone catabolic process (GO:0042447) | 4.92229823 |
| 25 | bile acid metabolic process (GO:0008206) | 4.86954892 |
| 26 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.85913485 |
| 27 | L-phenylalanine metabolic process (GO:0006558) | 4.85913485 |
| 28 | alkaloid metabolic process (GO:0009820) | 4.81645715 |
| 29 | ethanol metabolic process (GO:0006067) | 4.78262484 |
| 30 | regulation of bile acid biosynthetic process (GO:0070857) | 4.70004980 |
| 31 | NADH metabolic process (GO:0006734) | 4.68959696 |
| 32 | regulation of protein activation cascade (GO:2000257) | 4.65557231 |
| 33 | flavonoid metabolic process (GO:0009812) | 4.63820534 |
| 34 | regulation of fibrinolysis (GO:0051917) | 4.60706453 |
| 35 | negative regulation of cholesterol transport (GO:0032375) | 4.48793173 |
| 36 | negative regulation of sterol transport (GO:0032372) | 4.48793173 |
| 37 | regulation of complement activation (GO:0030449) | 4.45727058 |
| 38 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.43514285 |
| 39 | negative regulation of fibrinolysis (GO:0051918) | 4.40307600 |
| 40 | phenylpropanoid metabolic process (GO:0009698) | 4.35421370 |
| 41 | oxidative demethylation (GO:0070989) | 4.33110417 |
| 42 | phospholipid efflux (GO:0033700) | 4.30816185 |
| 43 | fructose metabolic process (GO:0006000) | 4.29529367 |
| 44 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.27178065 |
| 45 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.27178065 |
| 46 | arginine metabolic process (GO:0006525) | 4.25048687 |
| 47 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.23164773 |
| 48 | complement activation, classical pathway (GO:0006958) | 4.07951661 |
| 49 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.07018652 |
| 50 | regulation of cholesterol esterification (GO:0010872) | 4.06355418 |
| 51 | bile acid biosynthetic process (GO:0006699) | 3.95452810 |
| 52 | digestion (GO:0007586) | 3.95435666 |
| 53 | plasma lipoprotein particle remodeling (GO:0034369) | 3.89091021 |
| 54 | protein-lipid complex remodeling (GO:0034368) | 3.89091021 |
| 55 | macromolecular complex remodeling (GO:0034367) | 3.89091021 |
| 56 | lipoprotein transport (GO:0042953) | 3.85067339 |
| 57 | complement activation (GO:0006956) | 3.77781576 |
| 58 | regulation of guanylate cyclase activity (GO:0031282) | 3.76940322 |
| 59 | high-density lipoprotein particle remodeling (GO:0034375) | 3.76125120 |
| 60 | fibrinolysis (GO:0042730) | 3.76014108 |
| 61 | protein carboxylation (GO:0018214) | 3.74637514 |
| 62 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.74637514 |
| 63 | positive regulation of lipid catabolic process (GO:0050996) | 3.73894425 |
| 64 | protein activation cascade (GO:0072376) | 3.67615873 |
| 65 | plasma lipoprotein particle assembly (GO:0034377) | 3.66378136 |
| 66 | negative regulation of digestive system process (GO:0060457) | 3.62404738 |
| 67 | drug transmembrane transport (GO:0006855) | 3.56417353 |
| 68 | lipoprotein metabolic process (GO:0042157) | 3.56068045 |
| 69 | renal system process involved in regulation of blood volume (GO:0001977) | 3.55713604 |
| 70 | cholesterol efflux (GO:0033344) | 3.55180220 |
| 71 | aromatic amino acid family catabolic process (GO:0009074) | 3.52183956 |
| 72 | negative regulation of hemostasis (GO:1900047) | 3.50269809 |
| 73 | negative regulation of blood coagulation (GO:0030195) | 3.50269809 |
| 74 | drug transport (GO:0015893) | 3.49194150 |
| 75 | primary alcohol catabolic process (GO:0034310) | 3.48409711 |
| 76 | diacylglycerol metabolic process (GO:0046339) | 3.48082963 |
| 77 | daunorubicin metabolic process (GO:0044597) | 3.47007520 |
| 78 | polyketide metabolic process (GO:0030638) | 3.47007520 |
| 79 | doxorubicin metabolic process (GO:0044598) | 3.47007520 |
| 80 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.42424658 |
| 81 | acute-phase response (GO:0006953) | 3.40204469 |
| 82 | protein-lipid complex assembly (GO:0065005) | 3.34519280 |
| 83 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.33189527 |
| 84 | transcytosis (GO:0045056) | 3.33098964 |
| 85 | acylglycerol homeostasis (GO:0055090) | 3.30295617 |
| 86 | triglyceride homeostasis (GO:0070328) | 3.30295617 |
| 87 | vitamin biosynthetic process (GO:0009110) | 3.27933027 |
| 88 | heme transport (GO:0015886) | 3.27528452 |
| 89 | xenobiotic metabolic process (GO:0006805) | 3.25975257 |
| 90 | amino-acid betaine metabolic process (GO:0006577) | 3.24633271 |
| 91 | blood coagulation, intrinsic pathway (GO:0007597) | 3.24231734 |
| 92 | negative regulation of coagulation (GO:0050819) | 3.23738219 |
| 93 | reverse cholesterol transport (GO:0043691) | 3.23003387 |
| 94 | plasma lipoprotein particle organization (GO:0071827) | 3.22695340 |
| 95 | proline metabolic process (GO:0006560) | 3.20296054 |
| 96 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.16396424 |
| 97 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.15672012 |
| 98 | endocrine process (GO:0050886) | 3.15672012 |
| 99 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.15672012 |
| 100 | cholesterol homeostasis (GO:0042632) | 3.15598668 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.98682771 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.16737775 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.46530695 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.37745109 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.18305101 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.17494613 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.96499264 |
| 8 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 3.78954243 |
| 9 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.85188704 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.60402400 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.51684189 |
| 12 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.46955722 |
| 13 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.35967404 |
| 14 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.20578396 |
| 15 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.04696428 |
| 16 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.88158787 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.84090323 |
| 18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.81405952 |
| 19 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.80281974 |
| 20 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.80025701 |
| 21 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.79731898 |
| 22 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.78843152 |
| 23 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.78653915 |
| 24 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.74077741 |
| 25 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.72789143 |
| 26 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.61361806 |
| 27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.60530634 |
| 28 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.53294117 |
| 29 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.51813240 |
| 30 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.47063112 |
| 31 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.46250409 |
| 32 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.45617375 |
| 33 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.44347101 |
| 34 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.44039250 |
| 35 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.41819148 |
| 36 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.37320324 |
| 37 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.35701388 |
| 38 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.31691847 |
| 39 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31153357 |
| 40 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.26515358 |
| 41 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.23271027 |
| 42 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.19685170 |
| 43 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.17238635 |
| 44 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.16899007 |
| 45 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.15831622 |
| 46 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.13431524 |
| 47 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12081476 |
| 48 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.11751752 |
| 49 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.11430823 |
| 50 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.10891169 |
| 51 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.09921119 |
| 52 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.06782306 |
| 53 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06686883 |
| 54 | GATA1_22025678_ChIP-Seq_K562_Human | 1.06151477 |
| 55 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.05613918 |
| 56 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05069396 |
| 57 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.04670114 |
| 58 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03031537 |
| 59 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.00315633 |
| 60 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.99725055 |
| 61 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.99681830 |
| 62 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.99542436 |
| 63 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.98626154 |
| 64 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.97814424 |
| 65 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.96684375 |
| 66 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.95876943 |
| 67 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95742171 |
| 68 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.95331181 |
| 69 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.95007934 |
| 70 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.92447969 |
| 71 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.91736600 |
| 72 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90933258 |
| 73 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.90252244 |
| 74 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.90043779 |
| 75 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.89220654 |
| 76 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.87982095 |
| 77 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.83451589 |
| 78 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 0.83000175 |
| 79 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.81616362 |
| 80 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.80047818 |
| 81 | * SOX2_21211035_ChIP-Seq_LN229_Human | 0.79969225 |
| 82 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.78113239 |
| 83 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.77666786 |
| 84 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.74528482 |
| 85 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.74078548 |
| 86 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.73929395 |
| 87 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.73772309 |
| 88 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.73203663 |
| 89 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.73140670 |
| 90 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.72766243 |
| 91 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.71634436 |
| 92 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.71263774 |
| 93 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.71262414 |
| 94 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.70577423 |
| 95 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.70571816 |
| 96 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 0.70238725 |
| 97 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.69093354 |
| 98 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.69066647 |
| 99 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.68760613 |
| 100 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.68557673 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.89898852 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 7.66463281 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.93116849 |
| 4 | MP0005365_abnormal_bile_salt | 5.57117455 |
| 5 | MP0001666_abnormal_nutrient_absorption | 5.36489764 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.38015588 |
| 7 | MP0003868_abnormal_feces_composition | 3.32540555 |
| 8 | MP0009840_abnormal_foam_cell | 3.07280083 |
| 9 | MP0003252_abnormal_bile_duct | 3.00790629 |
| 10 | MP0004019_abnormal_vitamin_homeostasis | 2.65943542 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.62001736 |
| 12 | MP0002138_abnormal_hepatobiliary_system | 2.59750384 |
| 13 | MP0003195_calcinosis | 2.37123877 |
| 14 | MP0005332_abnormal_amino_acid | 2.32675418 |
| 15 | MP0010234_abnormal_vibrissa_follicle | 2.20337597 |
| 16 | MP0003183_abnormal_peptide_metabolism | 2.07295157 |
| 17 | MP0003806_abnormal_nucleotide_metabolis | 2.07187054 |
| 18 | MP0010155_abnormal_intestine_physiology | 1.87138533 |
| 19 | MP0009379_abnormal_foot_pigmentation | 1.81785457 |
| 20 | MP0004264_abnormal_extraembryonic_tissu | 1.76181889 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 1.71553131 |
| 22 | MP0002876_abnormal_thyroid_physiology | 1.68889073 |
| 23 | MP0002118_abnormal_lipid_homeostasis | 1.64550250 |
| 24 | MP0001664_abnormal_digestion | 1.58256320 |
| 25 | MP0001764_abnormal_homeostasis | 1.58131366 |
| 26 | MP0009643_abnormal_urine_homeostasis | 1.57581187 |
| 27 | MP0000609_abnormal_liver_physiology | 1.52747855 |
| 28 | MP0004147_increased_porphyrin_level | 1.45987856 |
| 29 | MP0005670_abnormal_white_adipose | 1.44292439 |
| 30 | MP0000490_abnormal_crypts_of | 1.30926433 |
| 31 | MP0005409_darkened_coat_color | 1.24698342 |
| 32 | MP0003879_abnormal_hair_cell | 1.19361976 |
| 33 | MP0003866_abnormal_defecation | 1.17631452 |
| 34 | MP0005451_abnormal_body_composition | 1.16118144 |
| 35 | MP0009697_abnormal_copulation | 1.15456589 |
| 36 | MP0000462_abnormal_digestive_system | 1.14156900 |
| 37 | MP0005636_abnormal_mineral_homeostasis | 1.11467934 |
| 38 | MP0001663_abnormal_digestive_system | 1.09277668 |
| 39 | MP0005319_abnormal_enzyme/_coenzyme | 1.07815824 |
| 40 | MP0005166_decreased_susceptibility_to | 1.05652185 |
| 41 | MP0005381_digestive/alimentary_phenotyp | 1.02343867 |
| 42 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.01742724 |
| 43 | MP0004782_abnormal_surfactant_physiolog | 0.98889788 |
| 44 | MP0000477_abnormal_intestine_morphology | 0.95662133 |
| 45 | MP0002971_abnormal_brown_adipose | 0.91270548 |
| 46 | MP0005448_abnormal_energy_balance | 0.91259725 |
| 47 | MP0002136_abnormal_kidney_physiology | 0.89684688 |
| 48 | MP0009642_abnormal_blood_homeostasis | 0.82845532 |
| 49 | MP0005535_abnormal_body_temperature | 0.81774824 |
| 50 | MP0001765_abnormal_ion_homeostasis | 0.81242922 |
| 51 | MP0001873_stomach_inflammation | 0.80281317 |
| 52 | MP0000678_abnormal_parathyroid_gland | 0.79612042 |
| 53 | MP0008872_abnormal_physiological_respon | 0.79476558 |
| 54 | MP0008469_abnormal_protein_level | 0.79473739 |
| 55 | MP0009764_decreased_sensitivity_to | 0.78753165 |
| 56 | MP0004043_abnormal_pH_regulation | 0.76599805 |
| 57 | MP0000598_abnormal_liver_morphology | 0.74801752 |
| 58 | MP0000604_amyloidosis | 0.71994758 |
| 59 | MP0001756_abnormal_urination | 0.71967842 |
| 60 | MP0010352_gastrointestinal_tract_polyps | 0.71294427 |
| 61 | MP0003718_maternal_effect | 0.70660906 |
| 62 | MP0005058_abnormal_lysosome_morphology | 0.69132812 |
| 63 | MP0005083_abnormal_biliary_tract | 0.68866519 |
| 64 | MP0000538_abnormal_urinary_bladder | 0.68746038 |
| 65 | MP0009785_altered_susceptibility_to | 0.67908722 |
| 66 | MP0001845_abnormal_inflammatory_respons | 0.67903209 |
| 67 | MP0002078_abnormal_glucose_homeostasis | 0.62290205 |
| 68 | MP0005666_abnormal_adipose_tissue | 0.62043404 |
| 69 | MP0004858_abnormal_nervous_system | 0.61939236 |
| 70 | MP0002796_impaired_skin_barrier | 0.57568754 |
| 71 | MP0002098_abnormal_vibrissa_morphology | 0.56769920 |
| 72 | MP0000566_synostosis | 0.56228834 |
| 73 | MP0005334_abnormal_fat_pad | 0.56163975 |
| 74 | MP0005165_increased_susceptibility_to | 0.55639816 |
| 75 | MP0003638_abnormal_response/metabolism_ | 0.55219584 |
| 76 | MP0005376_homeostasis/metabolism_phenot | 0.55154009 |
| 77 | MP0002822_catalepsy | 0.54726599 |
| 78 | MP0009763_increased_sensitivity_to | 0.53492026 |
| 79 | MP0008004_abnormal_stomach_pH | 0.53485412 |
| 80 | MP0005408_hypopigmentation | 0.52702703 |
| 81 | MP0000249_abnormal_blood_vessel | 0.52325759 |
| 82 | MP0003329_amyloid_beta_deposits | 0.50358097 |
| 83 | MP0003959_abnormal_lean_body | 0.48968242 |
| 84 | MP0005395_other_phenotype | 0.47810916 |
| 85 | MP0009115_abnormal_fat_cell | 0.47489448 |
| 86 | MP0002089_abnormal_postnatal_growth/wei | 0.46491436 |
| 87 | MP0003953_abnormal_hormone_level | 0.46300065 |
| 88 | MP0002249_abnormal_larynx_morphology | 0.44562927 |
| 89 | MP0001501_abnormal_sleep_pattern | 0.42051711 |
| 90 | MP0003436_decreased_susceptibility_to | 0.41719606 |
| 91 | MP0010368_abnormal_lymphatic_system | 0.41568617 |
| 92 | MP0000230_abnormal_systemic_arterial | 0.41121798 |
| 93 | MP0002132_abnormal_respiratory_system | 0.40641545 |
| 94 | MP0003300_gastrointestinal_ulcer | 0.40332991 |
| 95 | MP0001881_abnormal_mammary_gland | 0.38096063 |
| 96 | MP0000470_abnormal_stomach_morphology | 0.37652016 |
| 97 | MP0005501_abnormal_skin_physiology | 0.37599000 |
| 98 | MP0000467_abnormal_esophagus_morphology | 0.35806289 |
| 99 | MP0005025_abnormal_response_to | 0.35151754 |
| 100 | MP0005023_abnormal_wound_healing | 0.34743877 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 8.18578864 |
| 2 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 8.01175707 |
| 3 | Hypobetalipoproteinemia (HP:0003563) | 7.02453399 |
| 4 | Complement deficiency (HP:0004431) | 6.36840641 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 5.99210907 |
| 6 | Deep venous thrombosis (HP:0002625) | 5.53336163 |
| 7 | Abnormality of complement system (HP:0005339) | 5.49232734 |
| 8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.30286124 |
| 9 | Fat malabsorption (HP:0002630) | 5.28648778 |
| 10 | Hydroxyprolinuria (HP:0003080) | 4.99714501 |
| 11 | Abnormality of proline metabolism (HP:0010907) | 4.99714501 |
| 12 | Conjugated hyperbilirubinemia (HP:0002908) | 4.91967693 |
| 13 | Prolonged partial thromboplastin time (HP:0003645) | 4.73034072 |
| 14 | Malnutrition (HP:0004395) | 4.64410250 |
| 15 | Xanthomatosis (HP:0000991) | 4.53389868 |
| 16 | Glomerulonephritis (HP:0000099) | 4.22657534 |
| 17 | Steatorrhea (HP:0002570) | 4.22441815 |
| 18 | Intrahepatic cholestasis (HP:0001406) | 4.12503851 |
| 19 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.94635925 |
| 20 | Hypolipoproteinemia (HP:0010981) | 3.86195765 |
| 21 | Hyperlipoproteinemia (HP:0010980) | 3.70855055 |
| 22 | Hyperammonemia (HP:0001987) | 3.60863947 |
| 23 | Hyperglycinuria (HP:0003108) | 3.58820834 |
| 24 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.54009930 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 3.54009930 |
| 26 | Hemorrhage of the eye (HP:0011885) | 3.34798233 |
| 27 | Nephritis (HP:0000123) | 3.33943608 |
| 28 | Abnormality of vitamin metabolism (HP:0100508) | 3.26077140 |
| 29 | Joint hemorrhage (HP:0005261) | 3.25182206 |
| 30 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.15764194 |
| 31 | Ileus (HP:0002595) | 3.14138870 |
| 32 | Alkalosis (HP:0001948) | 3.02921827 |
| 33 | Abnormality of nucleobase metabolism (HP:0010932) | 3.02865982 |
| 34 | Glycosuria (HP:0003076) | 3.01671723 |
| 35 | Abnormality of urine glucose concentration (HP:0011016) | 3.01671723 |
| 36 | Widely patent fontanelles and sutures (HP:0004492) | 2.99462800 |
| 37 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.94979172 |
| 38 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.84137870 |
| 39 | Acanthocytosis (HP:0001927) | 2.69990810 |
| 40 | Proximal tubulopathy (HP:0000114) | 2.68281774 |
| 41 | Gout (HP:0001997) | 2.67135472 |
| 42 | Abnormality of vitamin B metabolism (HP:0004340) | 2.65043332 |
| 43 | Chronic diarrhea (HP:0002028) | 2.63978178 |
| 44 | Metabolic acidosis (HP:0001942) | 2.61038824 |
| 45 | Abnormality of purine metabolism (HP:0004352) | 2.60804758 |
| 46 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.59923559 |
| 47 | Epidermoid cyst (HP:0200040) | 2.55950773 |
| 48 | Hyperuricemia (HP:0002149) | 2.54013725 |
| 49 | Increased purine levels (HP:0004368) | 2.54013725 |
| 50 | Confusion (HP:0001289) | 2.53811622 |
| 51 | Delayed CNS myelination (HP:0002188) | 2.53044755 |
| 52 | Vascular calcification (HP:0004934) | 2.51327281 |
| 53 | Rickets (HP:0002748) | 2.49485129 |
| 54 | Nephrolithiasis (HP:0000787) | 2.48403205 |
| 55 | Hyperphosphaturia (HP:0003109) | 2.46790366 |
| 56 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.45720188 |
| 57 | Hypophosphatemia (HP:0002148) | 2.44002629 |
| 58 | Abdominal distention (HP:0003270) | 2.39643434 |
| 59 | Hyperglycinemia (HP:0002154) | 2.38817371 |
| 60 | Hyperactive renin-angiotensin system (HP:0000841) | 2.35070904 |
| 61 | Abnormality of the common coagulation pathway (HP:0010990) | 2.34875124 |
| 62 | Nausea (HP:0002018) | 2.34286767 |
| 63 | Abnormal urine phosphate concentration (HP:0012599) | 2.34207802 |
| 64 | Cerebral palsy (HP:0100021) | 2.32363458 |
| 65 | Generalized aminoaciduria (HP:0002909) | 2.32078319 |
| 66 | Pigmentary retinal degeneration (HP:0001146) | 2.31356300 |
| 67 | Facial shape deformation (HP:0011334) | 2.28542930 |
| 68 | Potter facies (HP:0002009) | 2.28542930 |
| 69 | Pancreatitis (HP:0001733) | 2.27419241 |
| 70 | Cardiovascular calcification (HP:0011915) | 2.18843119 |
| 71 | Hypercholesterolemia (HP:0003124) | 2.17994172 |
| 72 | Wide cranial sutures (HP:0010537) | 2.16625107 |
| 73 | Hyperbilirubinemia (HP:0002904) | 2.15358871 |
| 74 | Irritability (HP:0000737) | 2.15210303 |
| 75 | Abnormality of the intrinsic pathway (HP:0010989) | 2.14449433 |
| 76 | Megaloblastic anemia (HP:0001889) | 2.12714062 |
| 77 | Thin bony cortex (HP:0002753) | 2.12213932 |
| 78 | Abnormality of serum amino acid levels (HP:0003112) | 2.11488789 |
| 79 | Metabolic alkalosis (HP:0200114) | 2.10437171 |
| 80 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.08632800 |
| 81 | Hypoalphalipoproteinemia (HP:0003233) | 2.07506917 |
| 82 | Focal segmental glomerulosclerosis (HP:0000097) | 2.07211509 |
| 83 | Dicarboxylic aciduria (HP:0003215) | 2.07014416 |
| 84 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.07014416 |
| 85 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.06088989 |
| 86 | Abnormal tarsal ossification (HP:0008369) | 2.05308537 |
| 87 | Spontaneous abortion (HP:0005268) | 2.04301601 |
| 88 | Elevated alkaline phosphatase (HP:0003155) | 2.01931822 |
| 89 | Azoospermia (HP:0000027) | 1.94847678 |
| 90 | Decreased circulating renin level (HP:0003351) | 1.89783473 |
| 91 | Congenital sensorineural hearing impairment (HP:0008527) | 1.89380570 |
| 92 | Hypotension (HP:0002615) | 1.88061563 |
| 93 | Poikilocytosis (HP:0004447) | 1.87432181 |
| 94 | Glomerulosclerosis (HP:0000096) | 1.84709311 |
| 95 | Lethargy (HP:0001254) | 1.83843624 |
| 96 | Hepatocellular carcinoma (HP:0001402) | 1.82949329 |
| 97 | Skin nodule (HP:0200036) | 1.77417169 |
| 98 | Renal tubular acidosis (HP:0001947) | 1.76898159 |
| 99 | Osteomalacia (HP:0002749) | 1.75731362 |
| 100 | Hypophosphatemic rickets (HP:0004912) | 1.74013924 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.68588620 |
| 2 | ACVR1B | 5.43479854 |
| 3 | MST1R | 5.32799747 |
| 4 | EPHA2 | 3.97887948 |
| 5 | RIPK1 | 3.78652054 |
| 6 | NEK1 | 3.47291440 |
| 7 | PRKG2 | 2.62761851 |
| 8 | FGFR4 | 2.42672977 |
| 9 | LMTK2 | 2.33516588 |
| 10 | MET | 1.97128463 |
| 11 | TRIB3 | 1.87469750 |
| 12 | STK39 | 1.86826681 |
| 13 | MAP3K10 | 1.82052200 |
| 14 | EPHA3 | 1.79703505 |
| 15 | PTK6 | 1.71320106 |
| 16 | PIK3CA | 1.68926386 |
| 17 | EPHB2 | 1.61165613 |
| 18 | TYK2 | 1.56610362 |
| 19 | PRPF4B | 1.44451523 |
| 20 | MAP3K2 | 1.42106350 |
| 21 | PDK2 | 1.38934801 |
| 22 | OXSR1 | 1.38653265 |
| 23 | SIK1 | 1.34803591 |
| 24 | EPHB1 | 1.34774238 |
| 25 | MAP2K2 | 1.20576209 |
| 26 | MAP3K12 | 1.12446411 |
| 27 | TESK2 | 1.09652630 |
| 28 | GRK6 | 1.06037984 |
| 29 | MAP3K1 | 1.02386642 |
| 30 | ERBB2 | 0.99902457 |
| 31 | MYLK | 0.98506032 |
| 32 | PDPK1 | 0.98388762 |
| 33 | MAP3K3 | 0.97996733 |
| 34 | MATK | 0.95695330 |
| 35 | TESK1 | 0.95142137 |
| 36 | PRKACG | 0.93599329 |
| 37 | TAOK1 | 0.92389997 |
| 38 | DDR2 | 0.92115703 |
| 39 | DYRK1B | 0.88990501 |
| 40 | TBK1 | 0.88975782 |
| 41 | MAPK11 | 0.87980499 |
| 42 | PRKAA2 | 0.86393992 |
| 43 | MAP3K11 | 0.84938449 |
| 44 | IRAK3 | 0.83710286 |
| 45 | FER | 0.82181445 |
| 46 | FGFR3 | 0.81951288 |
| 47 | ZAP70 | 0.80885957 |
| 48 | EPHA4 | 0.80885561 |
| 49 | MAP2K6 | 0.74581481 |
| 50 | ABL2 | 0.72691402 |
| 51 | MAP4K1 | 0.71595360 |
| 52 | BCKDK | 0.70077155 |
| 53 | NLK | 0.69990016 |
| 54 | MST4 | 0.67257974 |
| 55 | PKN2 | 0.64096147 |
| 56 | IRAK1 | 0.62004378 |
| 57 | STK24 | 0.58847560 |
| 58 | PTK2 | 0.58654683 |
| 59 | PIK3CG | 0.58607273 |
| 60 | PDK1 | 0.57959651 |
| 61 | PRKCZ | 0.57871760 |
| 62 | CDC42BPA | 0.54605135 |
| 63 | RET | 0.51957027 |
| 64 | JAK1 | 0.51890605 |
| 65 | PRKCA | 0.51003255 |
| 66 | SRC | 0.48556591 |
| 67 | KSR2 | 0.44512247 |
| 68 | PBK | 0.43454585 |
| 69 | JAK2 | 0.42728097 |
| 70 | PIM2 | 0.42707790 |
| 71 | WNK4 | 0.40946315 |
| 72 | AKT3 | 0.40191860 |
| 73 | IGF1R | 0.39509779 |
| 74 | CSF1R | 0.38470322 |
| 75 | CAMK2D | 0.38178115 |
| 76 | PAK4 | 0.35717314 |
| 77 | CAMK2G | 0.35449595 |
| 78 | CDK6 | 0.35157809 |
| 79 | GRK1 | 0.33841595 |
| 80 | NME1 | 0.33281376 |
| 81 | TNIK | 0.29846153 |
| 82 | PRKCI | 0.29368000 |
| 83 | SMG1 | 0.29245692 |
| 84 | MAP3K14 | 0.28163756 |
| 85 | PDGFRA | 0.27741641 |
| 86 | BMX | 0.27649727 |
| 87 | RPS6KA2 | 0.25870605 |
| 88 | RIPK4 | 0.25159252 |
| 89 | PRKCD | 0.24602833 |
| 90 | PRKACA | 0.24059563 |
| 91 | TAOK2 | 0.23202224 |
| 92 | FYN | 0.21142884 |
| 93 | IKBKE | 0.19625631 |
| 94 | ICK | 0.19224851 |
| 95 | EEF2K | 0.18114310 |
| 96 | INSRR | 0.17880504 |
| 97 | PRKAA1 | 0.17146118 |
| 98 | MAP3K5 | 0.15151514 |
| 99 | TAOK3 | 0.15109358 |
| 100 | MAP2K1 | 0.15008020 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.85403846 |
| 2 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.45484603 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.30336357 |
| 4 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.29996006 |
| 5 | Retinol metabolism_Homo sapiens_hsa00830 | 3.04028478 |
| 6 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.00397284 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.81314482 |
| 8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.79581121 |
| 9 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.72481580 |
| 10 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.58827888 |
| 11 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.50079679 |
| 12 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.47088205 |
| 13 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.38981900 |
| 14 | Histidine metabolism_Homo sapiens_hsa00340 | 2.37433867 |
| 15 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.34230052 |
| 16 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.26280682 |
| 17 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.23486418 |
| 18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.20680996 |
| 19 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.19873013 |
| 20 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.07765736 |
| 21 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.04189238 |
| 22 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.92455866 |
| 23 | Bile secretion_Homo sapiens_hsa04976 | 1.87865042 |
| 24 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.75403861 |
| 25 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.73658682 |
| 26 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.69595139 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.66601103 |
| 28 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.66467463 |
| 29 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.55109081 |
| 30 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.53878078 |
| 31 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.45002742 |
| 32 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.42532580 |
| 33 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.40285235 |
| 34 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.35608863 |
| 35 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.31818193 |
| 36 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.28671256 |
| 37 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.23790355 |
| 38 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.22927628 |
| 39 | Mineral absorption_Homo sapiens_hsa04978 | 1.19187492 |
| 40 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.18527947 |
| 41 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.15178337 |
| 42 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.10531765 |
| 43 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.09659932 |
| 44 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.03323509 |
| 45 | Peroxisome_Homo sapiens_hsa04146 | 1.02172861 |
| 46 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.98685621 |
| 47 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.95778583 |
| 48 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.94855967 |
| 49 | Galactose metabolism_Homo sapiens_hsa00052 | 0.92542728 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.91664533 |
| 51 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.82449124 |
| 52 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.79289262 |
| 53 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.76055963 |
| 54 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.75525668 |
| 55 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.74895823 |
| 56 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.73450461 |
| 57 | Carbon metabolism_Homo sapiens_hsa01200 | 0.72380837 |
| 58 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.65884069 |
| 59 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.64283328 |
| 60 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.64263705 |
| 61 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.61430728 |
| 62 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.58693602 |
| 63 | Sulfur relay system_Homo sapiens_hsa04122 | 0.58610552 |
| 64 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.57190992 |
| 65 | ABC transporters_Homo sapiens_hsa02010 | 0.56270250 |
| 66 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.54375744 |
| 67 | Prion diseases_Homo sapiens_hsa05020 | 0.52357739 |
| 68 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.50109921 |
| 69 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.47733919 |
| 70 | Other glycan degradation_Homo sapiens_hsa00511 | 0.42939344 |
| 71 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41060032 |
| 72 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.38159738 |
| 73 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.35025937 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.26830085 |
| 75 | Pertussis_Homo sapiens_hsa05133 | 0.24479114 |
| 76 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23758761 |
| 77 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.20495135 |
| 78 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.19361227 |
| 79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.16234350 |
| 80 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.15045673 |
| 81 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.14554723 |
| 82 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.13424926 |
| 83 | Asthma_Homo sapiens_hsa05310 | 0.10344593 |
| 84 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.10267907 |
| 85 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09473379 |
| 86 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.08855386 |
| 87 | Lysine degradation_Homo sapiens_hsa00310 | 0.07132413 |
| 88 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.04707696 |
| 89 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.03797247 |
| 90 | Hepatitis C_Homo sapiens_hsa05160 | 0.01979741 |
| 91 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.00101383 |
| 92 | Tight junction_Homo sapiens_hsa04530 | -0.1078115 |
| 93 | Amoebiasis_Homo sapiens_hsa05146 | -0.1077701 |
| 94 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | -0.1035808 |
| 95 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | -0.1013471 |
| 96 | Steroid biosynthesis_Homo sapiens_hsa00100 | -0.0912046 |
| 97 | Allograft rejection_Homo sapiens_hsa05330 | -0.0799014 |
| 98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0558177 |
| 99 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0271852 |
| 100 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0191137 |

